Mahn-Soon Hwang
Director/Board Member chez BIO-SYNECTICS, INC.
Profil
Mahn-Soon Hwang is currently the Chief Executive Officer at Korea Investment Partners Co., Ltd.
He also holds non-executive director positions at GENEMATRIX, Inc., PCL, Inc., Bio-Synectics, Inc., Bioinfra Life Science, Inc., NGeneBio Co., Ltd., and TiumBio Co., Ltd.
In the past, Mr. Hwang has served as a non-executive director at CTC Bio, Inc., Bio Solution Co., Ltd., EyeGene, Inc., Asta, Inc. (South Korea), and Korea Biotech Investment Capital Co., Ltd.
He has also been an independent director at Kainos Medicine, Inc. .
Mr. Hwang completed his undergraduate and graduate degrees at Seoul National University.
Postes actifs de Mahn-Soon Hwang
| Sociétés | Poste | Début |
|---|---|---|
| BIO-SYNECTICS, INC. | Director/Board Member | 01/01/2009 |
| GENEMATRIX INC. | Director/Board Member | - |
| BIOINFRA LIFE SCIENCE INC. | Director/Board Member | - |
| TIUMBIO CO., LTD. | Director/Board Member | - |
| PCL, INC. | Director/Board Member | - |
| NGENEBIO CO., LTD. | Director/Board Member | - |
Korea Investment Partners Co., Ltd.
 Korea Investment Partners Co., Ltd. Investment ManagersFinance Korea Investment Partners Co., Ltd(Korea Investment Partners). is a Private Equity/Venture Capital firm, a subsidiary of Korea Investment Holdings Co., Ltd. founded in 1986. Korea Investment Partners Co., Ltd. is headquartered in Seoul. | Chief Executive Officer | - |
Anciens postes connus de Mahn-Soon Hwang
| Sociétés | Poste | Fin |
|---|---|---|
Kainos Medicine, Inc. /old/
 Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Kainos Medicine, Inc. specializes in the research and development of innovative medicines for brain diseases, cancers, and infectious disease. The company was founded by Ki-Sub Lee and Myung-Cheol Kang on June 15, 2007 and is headquartered in Seongnam-si, South Korea. | Director/Board Member | 17/11/2016 |
| EYEGENE INC. | Director/Board Member | - |
| ░░░ ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Mahn-Soon Hwang
| Seoul National University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 10 |
|---|---|
| CTCBIO INC. | Health Technology |
| BIO SOLUTION CO.,LTD. | Health Technology |
| GENEMATRIX INC. | Commercial Services |
| EYEGENE INC. | Health Technology |
| ASTA CORPORATION | Health Technology |
| PCL, INC. | Health Technology |
| BIO-SYNECTICS, INC. | Health Technology |
| BIOINFRA LIFE SCIENCE INC. | Health Technology |
| NGENEBIO CO., LTD. | Health Technology |
| TIUMBIO CO., LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Korea Investment Partners Co., Ltd.
Korea Investment Partners Co., Ltd. Investment ManagersFinance Korea Investment Partners Co., Ltd(Korea Investment Partners). is a Private Equity/Venture Capital firm, a subsidiary of Korea Investment Holdings Co., Ltd. founded in 1986. Korea Investment Partners Co., Ltd. is headquartered in Seoul. | Finance |
Korea Biotech Investment Capital Co., Ltd.
 Korea Biotech Investment Capital Co., Ltd. Investment ManagersFinance Korea Biotech Investment Capital Co., Ltd. (KBIC) is a private equity investment firm located in Seoul, South Korea. Established in 2000, KBIC is a subsidiary of Pulmuone Health & Living Co., Ltd. which manufactures and markets packaged fresh food and dietary supplement products. Pulmone traces their origins to 1955 when Won Kyung-sun opened a small cooperative farm to grow organic vegetables. In 1981 the current parent firm was created and in 1984 Won Hye-young officially established a food company with the same name. KBIC specializes in life-science related investments and is the investment manager of the KBIC Bio Fund 2. | Finance |
Kainos Medicine, Inc. /old/
Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Kainos Medicine, Inc. specializes in the research and development of innovative medicines for brain diseases, cancers, and infectious disease. The company was founded by Ki-Sub Lee and Myung-Cheol Kang on June 15, 2007 and is headquartered in Seongnam-si, South Korea. | Health Technology |
